Clinical efficacy analysis of furmonertinib and structural insights into sensitivity to diverse TKIs for NSCLC with EGFR exon 20 insertion.Xiao Zhang, Hong Tang, Guoxing Feng et al.|Journal of Clinical Oncology|2023Cited by 0
Significant benefit of high-dose furmonertinib in the treatment of leptomeningeal metastases from non-small-cell lung cancer with EGFR ex19Del mutation: Two case reports and a literature reviewHuan Han, Hong Tang, Jianwei Zhang et al.|Research Square|2023Cited by 0